Gavi, an alliance of public bodies and companies committed to saving lives through vaccination, announced the advanced-purchase commitment at the World Economic Forum held at Davos in the Swiss Alps
Dr Jeremy Farrar, the director of the Wellcome Trust medical research charity, said VSV-EBOV had shown "remarkable results" and was one of the "few positive outcomes" to emerge from the epidemic.
He said: "As we saw with the new confirmed case just last week, the Ebola epidemic is likely to have a long tail and it's possible that several more isolated cases will emerge in the coming weeks and months.
"This vaccine, therefore, could still play an important role in containing any additional flare-ups of this outbreak, as well as being available to help prevent future epidemics."
The Vaccine Alliance, Gavi, has
signed a $5m (£3.5m) deal for an Ebola vaccine, to protect against
future outbreaks of the deadly disease.
It will also submit an application to license the vaccine by the end of 2017, which would the next step towards enabling Gavi to prepare a global stockpile.
read more here
Post A Comment:
0 comments: